Compounds > atropine
Page last updated: 2024-09-05

atropine and n(6)-cyclopentyladenosine

atropine has been researched along with n(6)-cyclopentyladenosine in 4 studies

Compound Research Comparison

Studies
(atropine)		Trials
(atropine)		Recent Studies (post-2010)
(atropine)		Studies
(n(6)-cyclopentyladenosine)		Trials
(n(6)-cyclopentyladenosine)		Recent Studies (post-2010) (n(6)-cyclopentyladenosine)
26,7111,2591,697605062

Protein Interaction Comparison

ProteinTaxonomyatropine (IC50)n(6)-cyclopentyladenosine (IC50)
Adenosine receptor A1Rattus norvegicus (Norway rat)0.2256
Adenosine receptor A2bRattus norvegicus (Norway rat)1.16
Adenosine receptor A1Homo sapiens (human)0.0027
Adenosine receptor A2aRattus norvegicus (Norway rat)1.16

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (50.00)18.2507
2000's1 (25.00)29.6817
2010's1 (25.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Brodsky, JL; Chiang, A; Chung, WJ; Denny, RA; Goeckeler-Fried, JL; Havasi, V; Hong, JS; Keeton, AB; Mazur, M; Piazza, GA; Plyler, ZE; Rasmussen, L; Rowe, SM; Sorscher, EJ; Weissman, AM; White, EL1
Starke, K; Stoffel, D; von Kügelgen, I1
Biden, TJ; Browne, CL1
Tuovinen, K1

Other Studies

4 other study(ies) available for atropine and n(6)-cyclopentyladenosine

ArticleYear
Increasing the Endoplasmic Reticulum Pool of the F508del Allele of the Cystic Fibrosis Transmembrane Conductance Regulator Leads to Greater Folding Correction by Small Molecule Therapeutics.
    PloS one, 2016, Volume: 11, Issue:10

    Topics: Alleles; Benzoates; Cells, Cultured; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Endoplasmic Reticulum; Furans; Gene Deletion; HEK293 Cells; HeLa Cells; High-Throughput Screening Assays; Humans; Hydroxamic Acids; Microscopy, Fluorescence; Protein Folding; Protein Structure, Tertiary; Pyrazoles; RNA, Messenger; Small Molecule Libraries; Ubiquitination; Vorinostat

2016
P2-purinoceptor-mediated inhibition of noradrenaline release in rat atria.
    British journal of pharmacology, 1995, Volume: 115, Issue:2

    Topics: Adenosine; Adenosine Diphosphate; Adenosine Triphosphate; Animals; Antihypertensive Agents; Atropine; Desipramine; Dose-Response Relationship, Drug; Electric Stimulation; Heart Atria; Indomethacin; Male; Norepinephrine; Phenethylamines; Protein Synthesis Inhibitors; Purinergic P1 Receptor Antagonists; Purinergic P2 Receptor Antagonists; Rats; Rats, Wistar; Receptors, Purinergic P1; Receptors, Purinergic P2; Suramin; Triazines; Xanthines; Yohimbine

1995
Cross-talk between muscarinic- and adenosine-receptor signalling in the regulation of cytosolic free Ca2+ and insulin secretion.
    The Biochemical journal, 1993, Aug-01, Volume: 293 ( Pt 3)

    Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Adenosine; Atropine; Calcium; Calcium Channels; Carbachol; Cells, Cultured; Colforsin; Cytosol; Enzyme Activation; Glyceraldehyde; Insulin; Insulin Secretion; Ion Channel Gating; Muscarinic Antagonists; Receptors, Muscarinic; Receptors, Purinergic; Signal Transduction; Type C Phospholipases

1993
Organophosphate-induced convulsions and prevention of neuropathological damages.
    Toxicology, 2004, Mar-01, Volume: 196, Issue:1-2

    Topics: Acetylcholinesterase; Adenosine; Animals; Antidotes; Atropine; Brain; Cholinesterase Inhibitors; Diazepam; Dizocilpine Maleate; Excitatory Amino Acid Antagonists; GABA Modulators; Isoflurophate; Lung; Male; Nerve Tissue Proteins; Organophosphorus Compounds; Pralidoxime Compounds; Rats; Rats, Wistar; Seizures

2004